ADD ANI AS A TRUSTED SOURCE
googleads
ANI Logo
Menu
Science

Advanced MRI scans may improve treatment of tremors, Parkinson's disease: Study

Alabama [USA], June 20 (ANI): A new finding by researchers will enable experimental studies to determine whether and how pathogens play a role in triggering Parkinson's disease.

ANI Jun 20, 2020 19:32 IST googleads

Representative image

Alabama [USA], June 20 (ANI): A new finding by researchers will enable experimental studies to determine whether and how pathogens play a role in triggering Parkinson's disease.
Parkinson's disease (PD) is a common, progressive, and debilitating neurodegenerative disease which currently cannot be prevented or cured.
In 2003, Heiko Braak proposed that non-inherited forms of PD are caused by a pathogen in the gut. He hypothesized that the pathogen could pass through the intestinal mucosal barrier and spread to the brain through the nervous system. Up to now, there has been no evidence of a specific pathogen that may trigger PD.
Now Haydeh Payami, Ph.D., professor of neurology at the University of Alabama at Birmingham, and colleagues report for the first time a significant overabundance of a cluster of opportunistic pathogens in the guts of persons with PD, compared to control subjects.
"The exciting question is whether these are Braak's pathogens capable of triggering PD, or are they irrelevant to PD but able to penetrate the gut and grow because the gut lining is compromised in PD," Payami said.
"We emphasize that no claims can be made on function based solely on the association. The identity of these microorganisms will enable experimental studies to determine whether and how they play a role in PD," Payami added.
Payami and colleagues at UAB, Emory University, Albany Medical College, and the University of Washington were able to identify these microorganisms because they performed the largest microbiome-wide association study of persons with PD and controls to date.
Many previous studies have found altered gut microbiomes in persons with PD but did not detect an increase in opportunistic pathogens. Opportunistic pathogens are often harmless, but they can grow and cause infections if the immune system is compromised or if they penetrate into sterile sites of the body.
"We suspect the reason we were able to detect these microorganisms is that they are rare and we had a much larger sample size and power than prior studies," Payami said. Her researchers re-analyzed their 2017 study that had 197 cases and 130 controls, using a more advanced bioinformatics pipeline.
They also analyzed a new, independent dataset with 323 cases of PD and 184 controls, in parallel to the first dataset. This allowed internal replication and the power to detect both rare and common signals. Previous PD microbiome studies have ranged from 10 to 197 PD cases and 10 to 130 controls.
A microbiome-wide association study uses advances in DNA sequencing and computational tools to look for microbial communities that may be associated with the disease. There is an emerging understanding that the gut microbiome -- which includes 500 to 1,000 bacterial species that have a mainly beneficial influence -- plays an important role in human health and disease.
Payami and colleagues also used hypothesis-free correlation network analysis to identify communities of co-occurring microorganisms. Network analysis is an important new tool in biology.
An easily understood example of networks is a social network like Facebook, where one can map the connections between followers or friends. A few people will have a huge number of connections, some will have many, and a vast majority will have much fewer. A map of these connections is akin to an airline route map.
Using network analysis, Payami and colleagues found three polymicrobial clusters and also found that each cluster shared functional characteristics. The first cluster was that of opportunistic pathogens overabundant in PD cases, a novel finding.
The other two clusters were confirmatory of previous studies. In comparison to controls, persons with PD had reduced levels of a cluster of microbes that produce short-chain fatty acids. In the third cluster, the persons with PD had elevated levels of two genera that are carbohydrate-metabolizing probiotic microbes.
Payami says the current study had a precise focus and an intentionally strict analytic execution. The rigour of the study included showing that the altered gut microbiomes in the PD cases were independent of sex, age, BMI, constipation, gastrointestinal discomfort, geography, and diet. The 15 PD-associated genera that achieved microbiome-wide significance in both datasets were identified using two methods, and with or without covariate adjustment.
"There is more to be learned," Payami said, "with larger sample sizes with greater power, longitudinal studies to track change from prodromal to advanced disease, and by next-generation metagenome sequencing to broaden the scope from bacteria and archaea to include viruses and fungi, and improve the resolution to strain and gene level." (ANI)

Get the App

What to Read Next

Science

Strand Life Sciences launches portal for rare disease diagnosis

Strand Life Sciences launches portal for rare disease diagnosis

Marking Rare Disease Day, Strand Life Sciences, a subsidiary of Reliance Industries and a leading genomics research company, has launched the StrandOmics Portal, an innovative digital platform designed to assist doctors in diagnosing rare diseases more efficiently.

Read More
Science

COVID-19 severity may be predicted by White Blood Cell Count

COVID-19 severity may be predicted by White Blood Cell Count

A COVID-19 diagnosis is no longer as frightening as it used to be, thanks to developments in treatment choices. However, a new study reveals that leukocyte (white blood cell) count may now be used to identify who is more likely to develop more significant disease symptoms.

Read More
Science

Study finds novel approach to treat neurological diseases

Study finds novel approach to treat neurological diseases

The matter of what causes complicated neurological disorders like Alzheimer's or multiple sclerosis continues to perplex scientists and doctors, with unknowns impeding early diagnosis and successful treatment.

Read More
Science

Alzheimer’s disease can damage brain in two phases

Alzheimer’s disease can damage brain in two phases

Alzheimer's disease may cause brain damage in two stages, according to new research supported by the National Institutes of Health (NIH) that uses sophisticated brain mapping methods.

Read More
Science

Study discovers how special immune cells stop metastatic cancer

Study discovers how special immune cells stop metastatic cancer

The majority of cancer deaths are caused by metastatic disease, which occurs when cancer spreads from the primary tumour to other areas of the body. and researchers understand how cancer cells escape the primary location to seed new tumours, it is unclear why some cancer cells produce new tumours decades later and others do not.

Read More
Science

Study gives insights into possible cause of Alzheimer’s disease

Study gives insights into possible cause of Alzheimer’s disease

Researchers at Case Western Reserve University will investigate the possibility that specific brain proteins are involved in the onset of Alzheimer's disease.

Read More
Science

Researchers discover molecular mechanism for bacterial infection

Researchers discover molecular mechanism for bacterial infection

Researchers at Virginia Tech have discovered how bacteria change molecules in order to infect their host.

Read More
Science

Study finds how skin cancer occurrence in young adults declines

Study finds how skin cancer occurrence in young adults declines

A recent study suggested that the risk of malignant melanoma, or skin cancer, may be declining in Sweden, at least for people under the age of 50.

Read More
Science

Study finds new source of cardiac inflammation

Study finds new source of cardiac inflammation

Globally, ischemic heart disease is the leading cause of death. A myocardial infarction (MI), commonly referred to as a "heart attack," is the first event in which insufficient coronary blood flow results in the death of a portion of the heart. Heart failure, heart wall remodelling, and severe inflammation result from this.

Read More
Science

Study finds certain diabetes medications might prevent dementia

Study finds certain diabetes medications might prevent dementia

According to a study published, sodium-glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes may prevent dementia, with higher advantages with prolonged treatment.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.